Cover Image
市場調查報告書

Abera Bioscience AB 產品平台分析

Abera Bioscience AB - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 318949
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Abera Bioscience AB 產品平台分析 Abera Bioscience AB - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 20 Pages
簡介

Abera Bioscience AB 是在瑞典設有總公司的生物科技企業,正在從事針對流感、肺炎球菌疾病、結核、披衣菌感染等傳染病之疫苗及疫苗開發技術、口服及經鼻給藥的基因重組型活病毒疫苗、不活化疫苗、抗體、治療性蛋白質的藥物研發,研究開發及生產。

本報告提供Abera Bioscience AB 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Abera Bioscience AB 基本資料

  • Abera Bioscience AB 概要
  • 主要資訊
  • 企業資料

Abera Bioscience AB :R&D概要

  • 主要的治療範圍

Abera Bioscience AB :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Abera Bioscience AB :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Abera Bioscience AB :藥物簡介

  • chlamydia vaccine
  • influenza vaccine
  • pneumococcal vaccine (multivalent)
  • tuberculosis vaccine

Abera Bioscience AB :開發平台分析

  • 各給藥途徑
  • 各分子類型

Abera Bioscience AB :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06853CDB

Summary

Global Markets Direct's, 'Abera Bioscience AB - Product Pipeline Review - 2015', provides an overview of the Abera Bioscience AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Abera Bioscience AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Abera Bioscience AB including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Abera Bioscience AB's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Abera Bioscience AB's pipeline products

Reasons to buy

  • Evaluate Abera Bioscience AB's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Abera Bioscience AB in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Abera Bioscience AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Abera Bioscience AB and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Abera Bioscience AB
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Abera Bioscience AB and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Abera Bioscience AB Snapshot
    • Abera Bioscience AB Overview
    • Key Information
    • Key Facts
  • Abera Bioscience AB - Research and Development Overview
    • Key Therapeutic Areas
  • Abera Bioscience AB - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Abera Bioscience AB - Pipeline Products Glance
    • Abera Bioscience AB - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Abera Bioscience AB - Drug Profiles
    • Ab-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ab-02
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ab-03
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ab-04
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Abera Bioscience AB - Pipeline Analysis
  • Abera Bioscience AB - Pipeline Products by Route of Administration
  • Abera Bioscience AB - Pipeline Products by Molecule Type
  • Abera Bioscience AB - Dormant Projects
  • Abera Bioscience AB - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Abera Bioscience AB, Key Information
  • Abera Bioscience AB, Key Facts
  • Abera Bioscience AB - Pipeline by Indication, 2015
  • Abera Bioscience AB - Pipeline by Stage of Development, 2015
  • Abera Bioscience AB - Monotherapy Products in Pipeline, 2015
  • Abera Bioscience AB - Preclinical, 2015
  • Abera Bioscience AB - Discovery, 2015
  • Abera Bioscience AB - Pipeline by Route of Administration, 2015
  • Abera Bioscience AB - Pipeline by Molecule Type, 2015
  • Abera Bioscience AB - Dormant Developmental Projects,2015

List of Figures

  • Abera Bioscience AB - Pipeline by Top 10 Indication, 2015
  • Abera Bioscience AB - Pipeline by Stage of Development, 2015
  • Abera Bioscience AB - Monotherapy Products in Pipeline, 2015
  • Abera Bioscience AB - Pipeline by Top 10 Molecule Type, 2015
Back to Top